These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9529319)

  • 41. Is EPCR a multi-ligand receptor? Pros and cons.
    Montes R; Puy C; Molina E; Hermida J
    Thromb Haemost; 2012 May; 107(5):815-26. PubMed ID: 22318610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications.
    Okajima K
    Curr Vasc Pharmacol; 2004 Apr; 2(2):125-33. PubMed ID: 15320513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children.
    Moxon CA; Wassmer SC; Milner DA; Chisala NV; Taylor TE; Seydel KB; Molyneux ME; Faragher B; Esmon CT; Downey C; Toh CH; Craig AG; Heyderman RS
    Blood; 2013 Aug; 122(5):842-51. PubMed ID: 23741007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells.
    Bae JS; Yang L; Rezaie AR
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2867-72. PubMed ID: 17299037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma levels of endothelial protein C receptor respond to anticoagulant treatment.
    Stearns-Kurosawa DJ; Swindle K; D'Angelo A; Della Valle P; Fattorini A; Caron N; Grimaux M; Woodhams B; Kurosawa S
    Blood; 2002 Jan; 99(2):526-30. PubMed ID: 11781234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes.
    Grey ST; Hancock WW
    J Immunol; 1996 Mar; 156(6):2256-63. PubMed ID: 8690916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombomodulin, an endothelial anticoagulant; its structure, function and expression.
    Maruyama I
    Jpn Circ J; 1992 Feb; 56(2):187-91. PubMed ID: 1312651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early loss of thrombomodulin expression impairs vein graft thromboresistance: implications for vein graft failure.
    Kim AY; Walinsky PL; Kolodgie FD; Bian C; Sperry JL; Deming CB; Peck EA; Shake JG; Ang GB; Sohn RH; Esmon CT; Virmani R; Stuart RS; Rade JJ
    Circ Res; 2002 Feb; 90(2):205-12. PubMed ID: 11834714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect.
    Bouton MC; Venisse L; Richard B; Pouzet C; Arocas V; Jandrot-Perrus M
    Circ Res; 2007 Apr; 100(8):1174-81. PubMed ID: 17379830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factor VIIa binding to endothelial cell protein C receptor: differences between mouse and human systems.
    Sen P; Clark CA; Gopalakrishnan R; Hedner U; Esmon CT; Pendurthi UR; Rao LV
    Thromb Haemost; 2012 May; 107(5):951-61. PubMed ID: 22370814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). The structural and functional conservation in human, bovine, and murine EPCR.
    Fukudome K; Esmon CT
    J Biol Chem; 1995 Mar; 270(10):5571-7. PubMed ID: 7890676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor.
    Mosnier LO; Griffin JH
    Biochem J; 2003 Jul; 373(Pt 1):65-70. PubMed ID: 12683950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans.
    Lécuyer H; Virion Z; Barnier JP; Matczak S; Bourdoulous S; Bianchini E; Saller F; Borgel D; Nassif X; Coureuil M
    PLoS Pathog; 2018 Apr; 14(4):e1006981. PubMed ID: 29630665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell painting with an engineered EPCR to augment the protein C system.
    Bouwens EA; Stavenuiter F; Mosnier LO
    Thromb Haemost; 2015 Nov; 114(6):1144-55. PubMed ID: 26272345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells.
    Nan B; Yang H; Yan S; Lin PH; Lumsden AB; Yao Q; Chen C
    Surgery; 2005 Aug; 138(2):212-22. PubMed ID: 16153429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions. Evidence for a glycosaminoglycan-dependent secondary binding site for thrombin.
    Preissner KT; Koyama T; Müller D; Tschopp J; Müller-Berghaus G
    J Biol Chem; 1990 Mar; 265(9):4915-22. PubMed ID: 2156859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
    Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
    Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner.
    Shua F; Kobayashia H; Fukudomeb K; Tsuneyoshib N; Kimotob M; Teraoa T
    FEBS Lett; 2000 Jul; 477(3):208-12. PubMed ID: 10908722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
    Lopez-Ramirez MA; Pham A; Girard R; Wyseure T; Hale P; Yamashita A; Koskimäki J; Polster S; Saadat L; Romero IA; Esmon CT; Lagarrigue F; Awad IA; Mosnier LO; Ginsberg MH
    Blood; 2019 Jan; 133(3):193-204. PubMed ID: 30442679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inherited abnormalities in the protein C activation pathway.
    España F; Medina P; Navarro S; Estellés A; Aznar J
    Pathophysiol Haemost Thromb; 2002; 32(5-6):241-4. PubMed ID: 13679649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.